ARIELLE RANCOURT: Open Payments
NPI 1346970951 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$510 in 11 payments from 6 companies in 2025. Trend: 2023 $307 · 2024 $109 · 2025 $510
Food & beverage: $510
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 2 | $170 |
| Madrigal Pharmaceuticals | 3 | $163 |
| Ardelyx, Inc. | 2 | $59 |
| ABBVIE INC. | 2 | $53 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $34 |
| Janssen Biotech, Inc. | 1 | $31 |
Products named: REZDIFFRA, EXALT Model D, General - Biliary Devices, IBSRELA, LINZESS, ENTYVIO, TREMFYA.
Industry payments across NY — which companies pay providers there.
